Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: Wes Stevens who wrote (594)	3/31/1999 5:18:00 PM
From: Raven McCloud	Read Replies (1) \| Respond to of 2515

Well, if IMCL breaks thru $17 on good volume and holds above $17 I'll cover. And at this point in time this runup is on pure speculation. The preclinical trials mean jack. IMCl has a long, long way to go, IMO. So I missed this runup. If I get stopped out tomorrow I'll wait to come back on the short side again. Certainly not going to turn my position over and go long. I still think IMCL is way overbought. Congrats to all the longs who held out and advised me against my short position. Raven